Patient journey study for advanced gynecologic cancers
Part of Cancer, Women’s health & pregnancy clinical trials.
This study follows patients with advanced cervical or endometrial cancer after they finish their first standard treatments. It aims to understand their experiences and needs during this time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with stage III or IV cervical or endometrial cancer
- You finished your first treatment (chemotherapy, radiation, or both) between December 2022 and December 2024
- Your treatment was started within 6 months after your diagnosis
- Your doctor has told you that your cancer is stable right now
- You have not received newer targeted therapies like PD-1 or PD-L1 inhibitors
- You have not taken part in any other clinical trials before
- You have not had any additional treatments after your first therapy
- You can understand and speak the local language well
- You do not have significant hearing problems that would make a conversation difficult
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at what patients with advanced gynecologic cancer expect from care, and how well their care needs are being met. It uses questionnaires to learn what support is most helpful, especially near the end of life.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
This study looks at how people with endometrial cancer manage their care and treatment. It aims to understand your experiences to help improve support for others.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This study asks patients with gynecologic cancers (ovary, uterus, cervix, and related organs) starting chemotherapy and their caregivers about their emotional needs and challenges. Researchers want to understand what support would help most during cancer treatment.
This study tests if personalized treatment plans, based on detailed genetic testing of your tumor, can help women with recurrent ovarian, cervical, or endometrial cancer. You will work with a team of specialists to find the best options for you.
Hear when a new Uterine Cervical Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.